Connect with us

Berita

85,3% Pemudik Puas, Burhanuddin Muhtadi Tegaskan Tingginya Kepuasan Mudik Lebaran 2026

Published

on

Jakarta – Indikator Politik Indonesia merilis hasil survei terbaru yang menunjukkan tingkat kepuasan publik terhadap penyelenggaraan Mudik Lebaran 2026 berada pada level sangat tinggi. Sebanyak 85,3 persen pemudik menyatakan puas terhadap pelayanan mudik tahun ini.

Founder dan Peneliti Utama Indikator Politik Indonesia, Prof. Burhanuddin Muhtadi, M.A., Ph.D., menjelaskan bahwa secara umum tingkat kepuasan masyarakat baik yang mudik maupun tidak melaksanakan mudik mencapai 80,8 persen, dengan peningkatan signifikan pada kelompok pemudik.

“Ini menunjukkan penyelenggaraan mudik Lebaran 2026 berjalan sangat baik dan mendapat apresiasi luas dari masyarakat,” ujarnya dalam paparan hasil survei, Selasa (7/4/2026).

Survei tersebut dilakukan melalui wawancara tatap muka pada 29 Maret hingga 4 April 2026 terhadap 1.200 responden menggunakan metode multistage random sampling, dengan margin of error 2,9 persen dan tingkat kepercayaan 95 persen.

Dari rincian survei, kategori “sangat puas” tercatat sebesar 10,8 persen (umum) dan 15,3 persen (pemudik), sementara “cukup puas” mendominasi dengan 70,0 persen pada kedua kategori. Adapun tingkat ketidakpuasan relatif rendah, yakni 7,1 persen (umum) dan 9,5 persen (pemudik), serta yang menyatakan tidak puas sama sekali berada di bawah 2 persen.

Hasil ini juga menunjukkan konsistensi kinerja dibanding tahun sebelumnya, di mana tingkat kepuasan publik pada 2026 tercatat hampir identik dengan 2025, baik pada kategori sangat puas maupun cukup puas.

Menanggapi hasil tersebut, Kakorlantas Polri Agus Suryonugroho menyampaikan apresiasi dan rasa syukur atas tingginya tingkat kepuasan masyarakat. Ia menegaskan capaian ini merupakan hasil kerja keras dan sinergi seluruh stakeholder dalam penyelenggaraan Operasi Ketupat 2026.

“Kami mengucapkan terima kasih yang sebesar-besarnya kepada seluruh masyarakat, kementerian/lembaga, TNI, Polri, pemerintah daerah, serta para pemangku kepentingan lainnya yang telah berkolaborasi dengan baik sehingga mudik tahun ini berjalan aman, lancar, dan berkeselamatan,” ujarnya.

Secara khusus, Kakorlantas juga menyampaikan penghormatan dan apresiasi kepada Kapolri Listyo Sigit Prabowo atas kepemimpinan, petunjuk, dan arahan strategis, serta keterlibatan langsung di lapangan dalam memastikan pengamanan mudik berjalan optimal.

“Terima kasih dan penghargaan setinggi-tingginya kepada Bapak Kapolri atas arahan, dukungan penuh, dan kehadiran langsung di lapangan yang menjadi motivasi bagi seluruh jajaran dalam memberikan pelayanan terbaik kepada masyarakat,” lanjutnya.

Capaian ini menjadi indikator kuat keberhasilan kolaborasi berbagai pihak dalam mewujudkan mudik Lebaran yang aman, nyaman, dan lancar, sekaligus mencerminkan peningkatan kualitas pelayanan Polri yang semakin humanis, responsif, dan berorientasi pada keselamatan masyarakat.

Continue Reading
Click to comment

Leave a Reply

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

Coronavirus disease 2019

Published

on

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Continue Reading

Berita

tc-check-test1

Published

on

tc-manager precheck test1 – https://test1.com

Continue Reading

Trending